首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1373380

全球妊娠检测市场 - 2023-2030

Global Pregnancy Testing Market - 2023-2030

出版日期: 2023年10月18日 | 出版商:

DataM Intelligence | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

怀孕测试寻找一种称为人类绒毛膜促性腺激素（HCG）的特殊激素，它是在怀孕期间在人体内产生的。妊娠测试透过检测人类绒毛膜促性腺激素 (HCG) 来发挥作用。在怀孕的最初几天，血液中的 HCG 水平每 2 至 3 天增加一倍，这表明怀孕正在进展。因此，HCG 的存在高于一定水平表明怀孕。

妊娠测试主要有两种类型：尿液测试和血液检查。很少进行血液检查，因为血液检查很昂贵，结果往往与尿液检查相同。验血不仅可以检测体内是否有妊娠激素，还可以确定体内荷尔蒙的含量。

市场动态：驱动因素与限制因素

妊娠检测试剂盒的技术进步

技术进步的增加和新产品的推出预计将提高市场成长。自孕测试需求的增加预计将促进市场成长。

例如，2022 年8 月9 日，澳洲新创公司Hoopsy 开发了一种可回收的妊娠测试笔，该测试笔99% 是由纸製成的，旨在阻止每年数以百万计的一次性塑胶版本最终进入垃圾掩埋场。

2023 年 2 月 7 日，高品质、有效的快速检测产品製造商和分销商 Abingdon Health plc 与 Salignostics 签署了新的分销协议，在英国和爱尔兰推出首款基于唾液的妊娠检测产品 Salistick。因此，各种产品推出的增加预计将推动市场成长。

克制

假阳性结果

缺乏认识和不准确的结果正在阻碍市场。大多数测试套件声称其准确度为 99%。然而，存在错误结果的可能性，因为准确性主要取决于品牌和不当使用等因素。

Pregnancy tests look for a special hormone called human chorionic gonadotropin (HCG) which is developed in a person's body during pregnancy. Pregnancy tests work by detecting human chorionic gonadotropin (HCG). The level of HCG in the blood doubles every 2 to 3 days during the first days of pregnancy, which indicates that the pregnancy is progressing. Thus, the presence of HCG above a certain level indicates pregnancy.

There are two main types of pregnancy tests, urine tests and blood tests. Blood tests are rarely done because they're expensive and tend to have the same result as a urine test. Blood test not only detects whether the pregnancy hormone is in the body, but can also determine how much of the hormone is present.

Market Dynamics: Drivers & Restraints

Technological advancements in pregnancy testing kits

The increase in technological advancements and the introduction of new products is expected to raise the market growth. The increase in the demand for self-pregnancy testing is expected to increase the market growth.

For instance, on August 9, 2022, Australian start-up Hoopsy created a recyclable pregnancy test that is 99 percent made out of paper, aiming to stop millions of single-use plastic versions ending up in landfill each year.

On February 7, 2023, Abingdon Health plc, manufacturer and distributor of high-quality and effective rapid tests, signed a new distribution agreement with Salignostics for the launch of Salistick the first saliva-based pregnancy test in the UK and Ireland. Thus, an increase in a variety of product launches is expected to drive the market growth.

Restraint

False positive results

Lack of awareness, and inaccurate results are hampering the market. Most of the test kits claim that they are 99% accurate. However, there is a possibility of false results, as the accuracy mainly depends on factors like the brand and improper usage.

Segment Analysis

The global pregnancy testing market is segmented based on product type, test type, distribution channel, and region.

Pregnancy test kits segment accounted for 39.5% of the market share

The pregnancy test kit detects the pregnancy hormone, human chorionic gonadotrophin (hCG), in the urine or serum. The test can be taken on the first day of the missing period. Continuous technological advancement in pregnancy test kits is a major factor expected to drive the market's growth. The demand for pregnancy test kits is increasing substantially owing to increasing incidences of unplanned pregnancies globally, driving the global pregnancy testing market.

For instance, on June 10, 2022, Mylab Discovery Solutions launched PregaScreen, an at-home pregnancy test kit that allows women to detect their pregnancy status themselves. With the launch of this test kit, the company marks its foray into the female healthcare segment.

Additionally, on April 14, 2022, Mankind Pharma's pregnancy test kit brand launched a new and advanced pregnancy detection test kit for the Indian market. With this launch, it strived to continually provide advanced testing solutions for confirming the pregnancy. Thus, an increase in the number of product launches is expected to raise the segment growth.

Geographical Analysis

North America is expected to hold a significant position in the global pregnancy testing market share

North American region accounted for the largest market share in 2021. The increased awareness among women leads to the increased demand for self-detecting pregnancy kits, growing fertility disorders, increased unplanned pregnancy rates, increased new product launches, and favorable government initiatives related to family planning.

For instance, according to the latest report in 2023 by the New York Times, the United States has long had one of the highest rates of unintended pregnancy in the world. It is estimated that 46 percent of pregnancies are now unintended.

Additionally, on July 14, 2023, 2San partnered with Proov to distribute their proprietary easy-to-use interpret, at-home fertility tests in select Hy-Vee stores across 8 states in the Midwest. Thus, the above factors are driving the market growth in the region.

COVID-19 Impact Analysis:

The COVID-19 has impacted the ventricular assist devices market positively. During this period there was a rapid increase in the sales of pregnancy kits and fertility kits. The increase in at-home test kit usage has increased the market growth. Thus, there in a rise in the pregnancy testing market growth during this period.

Competitive Landscape

The leading companies with a significant market share include: Abbott Laboratories, BioMerieux SA, EKF Diagnostics Holdings plc, Atlas Medical, Quidel Corporation, BIOSYNEX SA, NG BIOTECH SAS, Axis Medicare, Cardinal Health Inc., and Thermo Fisher Scientific Inc.

Key Developments

In June 2022, PregaScreen, introduced an at-home pregnancy test kit that enables women to determine their pregnancy status, was introduced by Mylab Discovery Solutions.
On March 12, 2021, Lia, has introduced a flushable, biodegradable pregnancy test.

Why Purchase the Report?

To visualize the global pregnancy testing market segmentation based on product type, test type, distribution channel and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of pregnancy testing market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global pregnancy testing market report would provide approximately 62 tables, 59 figures, and 185 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Test Type
3.3. Snippet by Distribution Channel
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Technological advancements in pregnancy testing kits
  - 4.1.1.2.
- 4.1.2. Restraints
  - 4.1.2.1. False positive results
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Pregnancy Test Kits *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.2.3. Strips/Dipsticks and Cards
- 7.2.4. Digital Devices
- 7.2.5. Midstream Kits
- 7.2.6. Cassettes
7.3. Fertility Test Kits
- 7.3.1. Line indicator kits
- 7.3.2. Digital devices
- 7.3.3. Others

8. By Test Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 8.1.2. Market Attractiveness Index, By Test Type
8.2. HCG Blood *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. HCG Urine
8.4. FSH Urine
8.5. LH Urine

9. By Distribution Channel

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.1.2. Market Attractiveness Index, By Distribution Channel
9.2. Online Sales *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Gynecology/ Fertility Clinics
9.4. Pharmacies/Drugstores
9.5. Hypermarkets and Supermarkets
9.6. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Abbott Laboratories *
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. BioMerieux SA
12.3. EKF Diagnostics Holdings plc
12.4. Atlas Medical
12.5. Quidel Corporation
12.6. BIOSYNEX SA
12.7. NG BIOTECH SAS
12.8. Axis Medicare
12.9. Cardinal Health Inc.
12.10. Thermo Fisher Scientific Inc.